safeti
efficaci
modifiedl
ml
canin
coronaviru
ccov
vaccin
strain
evalu
dog
seroneg
viru
neg
ccov
safeti
test
four
dog
inocul
two
intramuscular
two
oronas
rout
time
vaccin
dose
observ
period
day
dog
display
local
system
reaction
efficaci
test
eight
dog
vaccin
intramuscular
four
dogsgroup
oronas
rout
four
dogsgroup
b
two
dog
maintain
nonvaccin
control
dog
group
vaccin
viru
detect
faecal
sampl
viru
isol
vi
pcr
assay
dog
group
b
viru
reveal
six
median
day
pcr
twentyeight
day
later
vaccin
control
dog
challeng
field
ccov
strain
challeng
vaccin
dog
display
clinic
sign
dog
group
shed
viru
median
day
evalu
vi
median
day
evalu
pcr
viru
shed
observ
vi
pcr
assay
dog
group
b
two
control
dog
display
moder
clinic
sign
viru
detect
vi
median
day
start
day
postchalleng
dpc
pcr
assay
median
day
start
dpc
coronavirus
positivestrand
rna
virus
recent
classifi
order
nidoviral
mainli
basi
genom
organ
replic
strategi
de
vri
et
al
coronaviru
genom
consist
larg
open
read
frame
orf
end
encod
replicas
gene
downstream
replicas
gene
smaller
orf
encod
structur
protein
e
nucleocapsid
n
protein
number
presumpt
nonstructur
protein
larg
unknown
function
luytj
research
focus
protein
candid
antigen
coronaviru
vaccin
sinc
major
induc
virusneutr
antibodi
gebauer
et
al
function
protein
still
clear
although
major
immunolog
role
attribut
protein
aminoand
carboxytermini
protein
elicit
strong
immun
respons
enjuan
et
al
induc
antibodydepend
complementmedi
viru
neutral
vn
wood
et
al
role
ccov
induc
enter
ill
canid
subject
activ
investig
two
decad
viru
respons
mild
moder
enter
dog
young
pup
combin
pathogen
ill
may
sever
diarrhoea
vomit
dehydr
loss
appetit
even
death
evermann
et
al
appel
shed
ccov
faec
occur
rang
day
postinfect
keenan
et
al
tennant
et
al
howev
faecal
shed
infect
pup
detect
npcr
period
day
pratelli
et
al
pratelli
et
al
valu
ccov
vaccin
provid
adequ
immun
field
condit
controversi
although
efficaci
durat
immun
engend
inactiv
vaccin
substanti
kill
ccov
vaccin
licens
usa
recent
studi
low
efficaci
inactiv
ccov
vaccin
reduc
viral
shed
faec
dog
ccov
infect
describ
pratelli
et
al
modifiedl
ml
ccov
vaccin
licens
usa
rapidli
withdrawn
due
high
rate
seriou
advers
reaction
martin
wilson
et
al
ml
ccov
vaccin
avail
california
recent
licens
usa
appear
safe
durat
immun
claim
manufactur
unfortun
ccov
vaccin
combin
canin
cellgrown
distemp
vaccin
rockborn
strain
result
high
frequenc
postdistemp
enceph
carmichael
present
note
report
result
studi
safeti
efficaci
ml
ccov
vaccin
dog
administ
intramuscular
oronas
rout
fourteen
convent
dog
month
age
use
neg
ccov
antigen
faec
ccov
antibodi
experi
baselin
bodi
temperatur
white
blood
cell
wbc
count
establish
dog
averag
result
day
vaccin
experiment
studi
perform
accord
anim
health
wellb
regul
author
minist
health
itali
author
modifiedl
ccov
vaccin
strain
use
viru
origin
isol
faecal
sampl
dog
mild
enter
serial
passag
time
canin
cell
viru
passag
infect
titer
tcid
l
use
throughout
studi
stock
vaccin
test
steril
aerob
anaerob
bacteria
mycoplasma
mycet
contamin
virus
use
standard
method
test
safeti
ml
ccov
vaccin
four
dog
no
inocul
two
intramuscular
no
two
oronas
rout
no
time
vaccin
dose
inocul
efficaci
test
follow
inocul
dog
individu
isol
daili
observ
day
sign
ill
wbc
count
bodi
temperatur
virolog
assay
individu
faecal
sampl
collect
day
test
day
day
dog
bled
serolog
field
ccov
strain
isol
faecal
sampl
diarrhoeic
pup
marsilio
et
al
use
challeng
dog
viru
propag
primari
canin
embryon
kidney
cek
cell
three
passag
store
c
dog
immun
control
challeng
day
vaccin
anim
receiv
ml
viral
suspens
ml
intranas
ml
oral
titer
tcid
l
acclimat
period
day
dog
hous
separ
eight
dog
randomli
chosen
vaccin
intramuscular
inject
four
dogsgroup
oronas
rout
four
dogsgroup
b
ml
ml
ccov
strain
two
dog
maintain
nonvaccin
follow
vaccin
dog
observ
advers
local
system
reaction
faecal
sampl
collect
daili
day
postvaccin
dpv
twentyeight
day
later
vaccin
control
dog
challeng
ccov
strain
day
challeng
day
postchalleng
dpc
dog
examin
clinic
viru
shed
monitor
dog
gener
refractori
clinic
diseas
experiment
infect
ccov
protect
immun
assess
also
monitor
viru
shed
median
day
viru
shed
experiment
design
report
tabl
viru
isol
vi
faecal
sampl
homogen
wv
minim
essenti
medium
mem
centrifug
min
g
l
supernat
antibiot
iuml
penicillin
gml
streptomycin
gml
amphotericin
b
inocul
duplic
onto
freshli
trypsinis
cell
wellplat
contain
glass
slide
cell
observ
daili
cytopath
effect
cpe
h
fix
cold
aceton
test
immunofluoresc
test
use
ccov
monoclon
antibodi
gentli
suppli
dr
gill
chappui
merial
franc
sampl
consid
nega
tive
cpe
observ
three
serial
passag
addit
pcr
test
pratelli
et
al
use
detect
ccov
faecal
sampl
briefli
revers
transcript
perform
total
reaction
volum
l
contain
pcr
buffer
kcl
mm
trishcl
mm
ph
mgcl
mm
mm
deoxynucleotid
datp
dctp
dgtp
dttp
rnase
u
mulv
revers
transcriptas
u
random
hexam
u
synthesi
cdna
carri
c
min
follow
denatur
step
c
min
mixtur
brought
total
volum
l
contain
pcr
buffer
mgcl
mm
amplitaq
gold
dna
polymeras
u
pmol
primer
pcr
mixtur
subject
cycl
c
min
c
min
c
min
dna
thermal
cycler
blood
sampl
collect
dog
serolog
test
day
vaccin
later
dpv
addit
sampl
collect
day
challeng
dpc
elisa
viru
neutral
test
carri
describ
pratelli
et
al
vn
titer
express
geometr
mean
od
valu
median
valu
given
small
size
comparison
group
nonnorm
distribut
data
verifi
kolmogorovsmirnov
test
nonparametr
mannwhitney
utest
use
compar
durat
ccov
shed
vn
titer
elisa
od
valu
vaccin
challeng
pvalu
consid
signific
follow
intramuscular
oronas
inocul
time
vaccin
dose
dog
remain
normal
alert
throughout
observ
period
local
gener
reaction
vaccin
observ
wbc
count
perform
daili
order
evalu
total
leukocyt
remain
normal
viru
isol
pcr
assay
perform
faecal
sampl
two
dog
inocul
intramuscular
rout
neg
faecal
sampl
two
dog
inocul
oronas
rout
pcr
posit
day
start
dpv
serolog
test
vn
elisa
carri
dpv
indic
dog
develop
ccov
antibodi
titer
tabl
vaccin
vi
pcr
faecal
sampl
neg
dog
tabl
vn
test
dpv
dog
slight
increas
vn
antibodi
titer
elisa
test
highest
antibodi
valu
observ
dpv
od
fig
challeng
vaccin
dog
display
clinic
sign
shed
viru
day
median
valu
dpc
pcr
ccov
detect
day
median
valu
start
dpc
tabl
antibodi
titer
vaccin
dog
evalu
vn
test
increas
progress
three
dog
one
dog
geometr
mean
dpc
elisa
test
show
progress
increas
od
valu
reach
highest
valu
dpc
od
fig
vaccin
vi
faecal
sampl
neg
pcr
assay
reveal
ccov
sampl
day
median
valu
dpv
tabl
vn
test
antibodi
reach
valu
dpv
elisa
test
antibodi
reach
highest
valu
dpv
od
fig
challeng
vaccin
dog
clinic
sign
viru
shed
either
vi
pcr
assay
tabl
howev
seroconvers
dog
vn
elisa
test
vn
titer
two
dog
two
dog
geometr
mean
od
dpc
fig
two
control
dog
inocul
field
strain
develop
hyperthermia
dpc
mild
diarrhoea
dpc
faecal
sampl
viru
isol
respect
dpc
median
valu
pcr
viru
detect
respect
dpc
median
valu
tabl
antibodi
vn
test
increas
dpc
geometr
mean
elisa
test
highest
od
valu
reach
dpc
od
median
valu
fig
length
ccov
shed
well
antibodi
level
detect
vn
elisa
test
vaccin
show
statist
signific
differ
group
b
pvalu
mannwhitney
utest
comparison
statist
signific
differ
observ
ccov
challeng
group
b
regard
length
ccov
shed
detect
vi
pcr
regard
vn
antibodi
titer
pvalu
mannwhitney
utest
case
differ
length
viral
shed
group
control
dog
p
group
b
control
dog
p
signific
present
studi
report
safeti
efficaci
ml
ccov
vaccin
dog
local
system
advers
reaction
observ
vaccin
dog
vaccin
infecti
viru
detect
faecal
sampl
vi
ccov
nucleic
acid
pcr
assay
dog
inocul
intramuscular
rout
group
howev
viru
nucleic
acid
reveal
pcr
six
median
day
dog
inocul
oronas
rout
group
b
suggest
low
viral
titer
viral
remind
sampl
pratelli
et
al
gener
efficaci
vaccin
appear
satisfactori
consid
protect
coronaviru
infect
gener
correl
presenc
specif
antibodi
mucos
surfac
ogra
et
al
saif
murphi
signific
differ
observ
dog
group
intramuscular
vaccin
b
oronas
vaccin
p
stress
ccov
shed
challeng
observ
either
vi
pcr
dog
vaccin
oronas
rout
group
b
sera
dog
group
show
high
od
valu
elisa
test
confirm
test
substanti
sensit
vn
test
detect
antibodi
ccov
pratelli
et
al
ccov
challeng
evalu
reduct
challeng
viru
shed
faec
reveal
decreas
viru
vaccin
dog
compar
control
dog
dog
vaccin
oronas
rout
group
b
high
antibodi
valu
detect
elisa
test
protect
ccov
infect
complet
sinc
challeng
viru
never
detect
vi
pcr
assay
seem
plausibl
protect
observ
vaccin
group
might
modul
product
mucos
iga
ogra
et
al
murphi
data
product
faecal
iga
dog
intramuscular
oronas
administr
ml
ccov
vaccin
howev
may
specul
dog
vaccin
intramuscular
rout
low
level
faecal
iga
provid
partial
protect
challeng
insuffici
confer
complet
protect
observ
tgev
pig
saif
immun
mechan
protect
ccov
infect
still
clear
hypothes
ml
vaccin
inocul
oronas
rout
might
gener
strong
iga
product
gut
confer
complet
protect
infect
result
studi
interest
sever
reason
ccov
infect
alon
consid
minor
clinic
relev
past
dual
infect
ccov
pratelli
et
al
ccov
pratelli
et
al
observ
dog
sever
clinic
ill
due
enhanc
pathogen
dual
infect
polymicrobi
infect
common
high
densiti
popul
unvaccin
kennel
addit
epidemiolog
consider
relat
recent
find
ccov
shed
faec
infect
pup
occur
period
day
pratelli
et
al
therefor
seem
like
immun
dog
ccov
would
posit
epidemiolog
effect
studi
suggest
effect
vaccin
abl
induc
truli
protect
longliv
immun
infect
sought
control
spread
ccov
high
risk
dog
popul
